AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Alnylam Pharmaceuticals, Inc.

$165.00 -$235.17 (-58.77%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$174.00
Day Range
$163.30$180.61
Year Range
$163.30$479.79
Market Cap
22.1B
AVG Volume
1.87M
Trailing/Forward PE
8.1/17.95
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2027-02-11
Primary Exchange
NASDAQUS
Revenue (USD) · Q
0500M1B1.5B24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ALNY Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q31.46B
26 Q21.29B
26 Q11.17B
25 Q41.1B
25 Q31.25B
25 Q2773.69M
25 Q1594.19M
24 Q4593.17M
24 Q3500.92M
24 Q2659.83M
Net Income (USD) · Q
-1B01B2B3B24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ALNY Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q32.17B
26 Q2164.49M
26 Q1205.99M
25 Q4186.42M
25 Q3251.08M
25 Q2-66.28M
25 Q1-57.48M
24 Q4-83.76M
24 Q3-111.57M
24 Q2-16.89M
Operating Income (USD) · Q
-200M0200M400M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ALNY Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q3345.8M
26 Q2231.44M
26 Q1268.64M
25 Q4131.72M
25 Q3367.98M
25 Q2-16.2M
25 Q118.08M
24 Q4-105.16M
24 Q3-76.91M
24 Q248.61M
EBITDA · Q
Cash Flows · Q
EPS · Q
Expenses · Q
Cash & Debt · Q
Debt ratios · Q
Margins · Q
Return on Capital · Q
Shares Outstanding · Q
Dividends (USD) · Q
Employee Count
Book Value Per Share · Q
Total Assets · Q
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ALNY

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Feb 2027.

Alnylam Pharmaceuticals, Inc.
ALNY
Stockpicker

Video analysis: ALNY

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ALNY

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.